edda has been researched along with Thyroid Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czepczyński, R; Gryczyńska, M; Ruchała, M; Szczepanek-Parulska, E; Wyszomirska, A | 1 |
| Czepczyński, R; Gryczyńska, M; Ruchała, M | 1 |
| Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E | 1 |
| Czepczyński, R; Gryczyńska, M; Kosowicz, J; Mikołajczak, R; Sowiński, J; Ziemnicka, K | 1 |
1 trial(s) available for edda and Thyroid Neoplasms
| Article | Year |
|---|---|
Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Medullary; Edetic Acid; Female; Gastrins; Humans; Hydrazines; Indium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Organotechnetium Compounds; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms | 2007 |
3 other study(ies) available for edda and Thyroid Neoplasms
| Article | Year |
|---|---|
Cerebellar metastasis of papillary thyroid carcinoma detected with somatostatin receptor scintigraphy.
Topics: Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Cerebellar Neoplasms; Edetic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; Octreotide; Radionuclide Imaging; Receptors, Somatostatin; Technetium; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
99mTc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment.
Topics: Adult; Aged; Aged, 80 and over; Edetic Acid; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Octreotide; Organotechnetium Compounds; Recurrence; Thyroid Neoplasms; Treatment Failure; Young Adult | 2016 |
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution | 2007 |